Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-20-022057

CEO and CFO bought 2,000 shares at $5.40 ($10,795)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2020-11-19 Purchase +2,000 $5.40 $10,795 1,186,839 D: show line 1 in the form
Open-market purchases · 2,000 sh · avg $5.40 · $10,795
Loading xslF345X03/ownership.xml…